M. Angelos Stergiou's most recent trade in SELLAS Life Sciences Group Inc was a trade of 385,750 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Jan. 10, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
SELLAS Life Sciences Group...
|
Angelos M. Stergiou | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jan 2025 | 385,750 | 385,750 | - | - | Stock Option (Right to Buy) | |
SELLAS Life Sciences Group...
|
Angelos M. Stergiou | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jan 2025 | 257,000 | 615,132 (12%) | 5% | 0 | Common Stock | |
SELLAS Life Sciences Group...
|
Angelos M. Stergiou | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jan 2025 | 243,900 | 859,032 (16%) | 4% | 0 | Common Stock | |
SELLAS Life Sciences Group...
|
M. Angelos Stergiou | Director, President and CEO | Other type of transaction at price $ 1.13 per share. | 04 Dec 2024 | 28,289 | 358,132 (7%) | 0% | 1.1 | 31,967 | Common Stock |
SELLAS Life Sciences Group...
|
M. Angelos Stergiou | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jan 2024 | 238,500 | 238,500 | - | - | Stock Option (Right to Buy) | |
SELLAS Life Sciences Group...
|
Angelos Stergiou M. | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jan 2024 | 159,000 | 376,421 (7%) | 3% | 0 | Common Stock | |
SELLAS Life Sciences Group...
|
Angelos M. Stergiou | Director, President and CEO | Other type of transaction at price $ 1.08 per share. | 06 Dec 2023 | 12,268 | 217,421 (4%) | 0% | 1.1 | 13,249 | Class A Common Stock |
SELLAS Life Sciences Group...
|
Angelos M. Stergiou | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Feb 2023 | 217,500 | 217,500 | - | - | Stock Option (Right to Buy) | |
SELLAS Life Sciences Group...
|
Angelos M. Stergiou | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Feb 2023 | 58,000 | 219,689 (4%) | 1% | 0 | Common Stock | |
SELLAS Life Sciences Group...
|
Angelos M. Stergiou | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 2.61 per share. | 05 Dec 2022 | 6,494 | 161,689 | - | 2.6 | 16,938 | Class A Common Stock |
SELLAS Life Sciences Group...
|
Angelos M. Stergiou | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2022 | 165,000 | 165,000 | - | - | Stock Option (Right to Buy) | |
SELLAS Life Sciences Group...
|
Angelos M. Stergiou | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2022 | 44,000 | 165,167 (3%) | 0% | 0 | Common Stock |